The Florida Society of Rheumatology is sharing the following advocacy initiative from the Coalition of State Rheumatology Organizations (CSRO) and the American College of Rheumatology (ACR).
Protecting Patient Access to Cancer and Complex Therapies Act
The Coalition of State Rheumatology Organizations (CSRO) and the American College of Rheumatology (ACR) are acutely aware that the ASP is under attack and that adequate physician reimbursement for Part B drugs is crucial to ensure localized patient access to these essential mediations. This is why protecting ASP reimbursement is one of our top federal advocacy priorities.
CSRO & ACR are working together along with a large provider and patient coalition to advance the Protecting Patient Access to Cancer and Complex Therapies Act (HR4299), a bipartisan effort that would remove physician Part B drug reimbursement from the middle of Medicare Drug Price Negotiation Program (MDPNP) negotiations while maintaining the savings secured under the Inflation Reduction Act for the federal government and Medicare beneficiaries. What does this mean for rheumatologists: preventing a 40-60% cut in Part B reimbursements on select drugs starting in 2028.
Your members of Congress need to hear directly from their constituents, which is why we’re asking you to sign up and add your name to this letter encouraging your Senators and Representatives to cosponsor this important legislation.
Addresses an unintended effect of the Inflation Reduction Act by stabilizing Medicare Part B drug reimbursements for providers
Requires drug manufacturers to send rebates directly to the government for the difference in costs instead of involving providers through models currently proposed by CMS
Restores provider payment for a selected drug or biological under Medicare Part B to 106% of the average sales price (ASP)– thereby removing the Maximum Fair Price (MFP) from provider calculated reimbursement
By excluding MFP from the calculation of ASP, it also protects commercial reimbursement rates
CSRO Policy Resources:
Protecting Patient Access to Cancer and Complex Therapies Act: CSRO Issue Brief
Email to a Friend